KG

Kalpana Gupta

Active Director Director DIN 11515319
DIN 11515319 First appointment Jan 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kalpana Gupta

Data last updated:

Kalpana Gupta is a Director at Armektya Health Private Limited (since 2026) and Director at Aanch Health Private Limited (since 2026). The companies operate in Healthcare.

DIN 11515319
Primary Designation Director
Industry Healthcare
First Appointment 30 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Armektya Health Private Limited U86100RJ2026PTC116716
Director03 Aug 20262026Active
Aanch Health Private Limited U86900RJ2026PTC111150
Director30 Jan 20262026Active

Board colleagues of Kalpana Gupta

Directorship timeline

Open interactive timeline →
Aanch Health Private Limited
Armektya Health Private Limited
Premium access

Shareholding and investment profile for Kalpana Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalpana Gupta

Kalpana Gupta currently holds 2 directorships: Armektya Health Private Limited (Director, since 03 Aug 2026); Aanch Health Private Limited (Director, since 30 Jan 2026).

Kalpana Gupta was first appointed on 30 Jan 2026 as Director at Aanch Health Private Limited.

The current boards of Kalpana Gupta's companies include Mahendra Kumar Gupta (Armektya Health Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available